Exogenously Regulated Stem Cell-Mediated Gene Therapy for Bone Regeneration
Open Access
- 1 April 2001
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 3 (4), 449-461
- https://doi.org/10.1006/mthe.2001.0291
Abstract
Regulated expression of transgene production and function is of great importance for gene therapy. Such regulation can potentially be used to monitor and control complex biological processes. We report here a regulated stem cell-based system for controlling bone regeneration, utilizing genetically engineered mesenchymal stem cells (MSCs) harboring a tetracycline-regulated expression vector encoding the osteogenic growth factor human BMP-2. We show that doxycycline (a tetracycline analogue) is able to control hBMP-2 expression and thus control MSC osteogenic differentiation both in vitro and in vivo. Following in vivo transplantation of genetically engineered MSCs, doxycycline administration controlled both bone formation and bone regeneration. Moreover, our findings showed increased angiogenesis accompanied by bone formation whenever genetically engineered MSCs were induced to express hBMP-2 in vivo. Thus, our results demonstrate that regulated gene expression in mesenchymal stem cells can be used as a means to control bone healing.Keywords
This publication has 54 references indexed in Scilit:
- Direct Three-Dimensional Morphometric Analysis of Human Cancellous Bone: Microstructural Data from Spine, Femur, Iliac Crest, and CalcaneusJournal of Bone and Mineral Research, 1999
- Age-Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone MarrowJournal of Bone and Mineral Research, 1999
- Effects of bone morphogenetic protein-2 on human neonatal calvaria cell differentiationJournal of Cellular Biochemistry, 1999
- Dose-Dependent Doxycycline-Mediated Adrenocorticotropic Hormone Secretion from Encapsulated Tet-On Proopiomelanocortin Neuro2A Cells in the Subarachnoid SpaceHuman Gene Therapy, 1998
- Bone regeneration by implantation of purified, culture‐expanded human mesenchymal stem cellsJournal of Orthopaedic Research, 1998
- Growth/Differentiation Factor-5 Induces Angiogenesisin VivoExperimental Cell Research, 1997
- Effects of BMP-2, BMP-4, and BMP-6 on Osteoblastic Differentiation of Bone Marrow-Derived Stromal Cell Lines, ST2 and MC3T3-G2/PA6Biochemical and Biophysical Research Communications, 1996
- Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypesJournal of Bone and Mineral Research, 1994
- Bone Morphogenetic Protein-2 Causes Commitment and Differentiation in C3Hl0T1/2 and 3T3 CellsGrowth Factors, 1993
- The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2Biochemical and Biophysical Research Communications, 1990